H-Index
17
Scimago Lab
powered by Scopus
eISSN: 1941-5923
call: +1.631.629.4328
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
MSMbanner

Annals
ISI-Home

Unusual Early Recovery of a Critical COVID-19 Patient After Administration of Intravenous Vitamin C

Unusual clinical course, Unusual or unexpected effect of treatment

Hafiz Muhammad Waqas Khan, Niraj Parikh, Shady Maher Megala, George Silviu Predeteanu

USA Department of Cardiovascular Disease, McLaren-Flint/Michigan State University, Flint, MI, USA

Am J Case Rep 2020; 21:e925521

DOI: 10.12659/AJCR.925521

Available online: 2020-07-14

Published: 2020-07-25


#925521

BACKGROUND: Coronavirus disease 2019 (COVID-19) continues to spread, with confirmed cases now in more than 200 countries. Thus far there are no proven therapeutic options to treat COVID-19. We report a case of COVID-19 with acute respiratory distress syndrome who was treated with high-dose vitamin C infusion and was the first case to have early recovery from the disease at our institute.
CASE REPORT: A 74-year-old woman with no recent sick contacts or travel history presented with fever, cough, and shortness of breath. Her vital signs were normal except for oxygen saturation of 87% and bilateral rhonchi on lung auscultation. Chest radiography revealed air space opacity in the right upper lobe, suspicious for pneumonia. A nasopharyngeal swab for severe acute respiratory syndrome coronavirus-2 came back positive while the patient was in the airborne-isolation unit. Laboratory data showed lymphopenia and elevated lactate dehydrogenase, ferritin, and interleukin-6. The patient was initially started on oral hydroxychloroquine and azithromycin. On day 6, she developed ARDS and septic shock, for which mechanical ventilation and pressor support were started, along with infusion of high-dose intravenous vitamin C. The patient improved clinically and was able to be taken off mechanical ventilation within 5 days.
CONCLUSIONS: This report highlights the potential benefits of high-dose intravenous vitamin C in critically ill COVID-19 patients in terms of rapid recovery and shortened length of mechanical ventilation and ICU stay. Further studies will elaborate on the efficacy of intravenous vitamin C in critically ill COVID-19.

Keywords: Ascorbic Acid, COVID-19, Intensive Care Units, Respiration, Artificial



Back